This discrepancy may be explained by the fact that STRC mutations are most common among patients with mild-to-moderate NSHL, and our cohort consisted mostly of patients with profound NSHL. This evidence concerns the gene STRC and nodular sclerosis classical Hodgkin lymphoma.